Z-1161-2013 Class III Terminated
FDA device recall Z-1161-2013 was initiated by Ortho-Clinical Diagnostics on Nov 1, 2012 and is designated Class III. Reason for recall: Ortho Clinical Diagnostics is recalling certain lots of the Vitros Anti-HBs Reagent packs an inability to obtain a valid calibration. The recall status is terminated (terminated Mar 30, 2017). Affected quantity: 1464 units.
Recall details
- Product Type
- Devices
- Report Date
- May 1, 2013
- Initiation Date
- Nov 1, 2012
- Termination Date
- Mar 30, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1464 units
Product description
VITROS¿ Immunodiagnostic Products Anti-HBs (total antibody to hepatitis B surface antigen (anti-HBs)) Reagent Packs For the quantitative in vitro determination of total antibody to hepatitis B surface antigen (anti-HBs) in human serum.
Reason for recall
Ortho Clinical Diagnostics is recalling certain lots of the Vitros Anti-HBs Reagent packs an inability to obtain a valid calibration.
Distribution pattern
Worldwide Distribution- USA (nationwided) and countries of: Australia, Brazil, Canada, Chile, Chao Yang District, Beijing, Columbia, England, France, Germany, India, Italy, Japan, Mexico, Republic of Panama, Singapore, Spain and Venezuela.
Code information
Lot #'s 6630 expiration 2/26/2013, Lot # 6740 expiration 6/18/2013 and Lot # 6750 expiration date 6/11/2013.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1161-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026